×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中国医学科学院 北... [20]
大连理工大学 [2]
内容类型
期刊论文 [18]
会议论文 [4]
发表日期
2019 [4]
2018 [3]
2017 [3]
2016 [2]
2015 [8]
2014 [2]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共22条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
发表日期升序
发表日期降序
作者升序
作者降序
提交时间升序
提交时间降序
题名升序
题名降序
Evaluating stress, satisfaction and the associated influencing factors of participants in cancer clinical trials: a cross-sectional study in China
期刊论文
2019, 卷号: 9, 期号: 5, 页码: e028589
作者:
Jiang, Shiyu
;
Liu, Peng
;
Yang, Sheng
;
Yang, Jianliang
;
Wu, Dawei
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2020/01/03
cancer
clinical trials
patient satisfaction
stress
Promising efficacy of SHR-1210, a novel anti-programmed cell death 1 antibody, in patients with advanced gastric and gastroesophageal junction cancer in China
期刊论文
2019, 卷号: 125, 期号: 5, 页码: 742-749
作者:
Huang, Jing
;
Mo, Hongnan
;
Zhang, Weilong
;
Chen, Xuelian
;
Qu, Dong
收藏
  |  
浏览/下载:21/0
  |  
提交时间:2020/01/03
B7-H1 antigen
DNA mismatch repair
l-lactate dehydrogenase
programmed cell death 1 receptor
stomach neoplasms
Lactate dehydrogenase and baseline markers associated with clinical outcomes of advanced esophageal squamous cell carcinoma patients treated with camrelizumab (SHR-1210), a novel anti-PD-1 antibody
期刊论文
2019, 卷号: 10, 期号: 6, 页码: 1395-1401
作者:
Wang, Xi
;
Zhang, Bo
;
Chen, Xuelian
;
Mo, Hongnan
;
Wu, Dawei
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2020/01/03
Esophageal squamous cell carcinoma
immune checkpoint inhibitor
lactate dehydrogenase
markers
programmed cell death-1
Reactive capillary hemangiomas: a novel dermatologic toxicity following anti-PD-1 treatment with SHR-1210
期刊论文
2019, 卷号: 16, 期号: 1, 页码: 173-+
作者:
Chen, Xuelian
;
Ma, Lanying
;
Wang, Xi
;
Mo, Hongnan
;
Wu, Dawei
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2020/01/03
Reactive capillary hemangiomas
SHR-1210
skin toxicity
anti-tumor efficacy
Safety, Activity, and Biomarkers of SHR-1210, an Anti-PD-1 Antibody, for Patients with Advanced Esophageal Carcinoma
期刊论文
2018, 卷号: 24, 期号: 6, 页码: 1296-1304
作者:
Huang, Jing
;
Xu, Binghe
;
Mo, Hongnan
;
Zhang, Weilong
;
Chen, Xuelian
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2020/01/03
Safety, anti-tumour activity, and pharmacokinetics of fixed- dose SHR-1210, an anti-PD-1 antibody in advanced solid tumours: a dose-escalation, phase 1 study
期刊论文
2018, 卷号: 119, 期号: 5, 页码: 538-545
作者:
Mo, Hongnan
;
Huang, Jing
;
Xu, Jiachen
;
Chen, Xuelian
;
Wu, Dawei
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2020/01/03
Red blood cell distribution width as a related factor of pulmonary arterial hypertension in patients with systemic sclerosis
期刊论文
2018, 卷号: 37, 期号: 4, 页码: 979-985
作者:
Zhao, Jiuliang
;
Mo, Hongnan
;
Guo, Xiaoxiao
;
Wang, Qian
;
Xu, Dong
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2020/01/03
Inflammation
Pulmonary arterial hypertension
Red blood cell distribution width
Systemic sclerosis
Targeting MET in cancer therapy
期刊论文
2017, 卷号: 3, 期号: 3, 页码: 148-153
作者:
Mo Hongnan
;
Liu Peng
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2020/01/03
Proto-oncogene protein c-MET
Antineoplastic agents
Protein kinase inhibitors
Molecular targeted therapy
Phase I study of the anti-PD-1 antibody SHR-1210 in patients with advanced solid tumors.
会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20
作者:
Huang, Jing
;
Mo, Hongnan
;
Wu, Dawei
;
Chen, Xuelian
;
Ma, Lanying
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2020/01/04
Phase I study of the anti-PD-1 antibody SHR-1210 in patients with advanced solid tumors.
期刊论文
2017, 卷号: 35
作者:
Huang, Jing
;
Mo, Hongnan
;
Wu, Dawei
;
Chen, Xuelian
;
Ma, Lanying
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2020/01/04
©版权所有 ©2017 CSpace - Powered by
CSpace